These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17961802)

  • 1. Polymorphisms in the survivin gene and the risk of lung cancer.
    Jang JS; Kim KM; Kang KH; Choi JE; Lee WK; Kim CH; Kang YM; Kam S; Kim IS; Jun JE; Jung TH; Park JY
    Lung Cancer; 2008 Apr; 60(1):31-39. PubMed ID: 17961802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
    Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
    Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma.
    Yang X; Xiong G; Chen X; Xu X; Wang K; Fu Y; Yang K; Bai Y
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1341-9. PubMed ID: 19352701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
    Cheng ZJ; Hu LH; Huang SJ
    Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
    Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
    Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
    Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT3B polymorphisms and risk of primary lung cancer.
    Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
    Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
    Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
    Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
    Jaiswal PK; Goel A; Mandhani A; Mittal RD
    Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
    Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
    Hmeljak J; Erčulj N; Dolžan V; Kern I; Cör A
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1641-51. PubMed ID: 21861135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population.
    Kang HG; Lee SJ; Chae MH; Lee WK; Cha SI; Kim CH; Kam S; Park RW; Kim IS; Kim DS; Kim YC; Jung TH; Park JY
    Cancer Genet Cytogenet; 2008 Jan; 180(1):6-13. PubMed ID: 18068526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin polymorphisms and susceptibility to prostate cancer: A genetic association study and an
    Karimian M; Aftabi Y; Mazoochi T; Babaei F; Khamechian T; Boojari H; Nikzad H
    EXCLI J; 2018; 17():479-491. PubMed ID: 30034311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
    Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
    PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
    Srivastava K; Srivastava A; Mittal B
    Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
    Javid J; Mir R; Julka PK; Ray PC; Saxena A
    Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk.
    Jang JS; Kim KM; Choi JE; Cha SI; Kim CH; Lee WK; Kam S; Jung TH; Park JY
    Mol Carcinog; 2008 May; 47(5):383-90. PubMed ID: 18058802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population.
    Han SG; Park KH; Sung JS; Whang YM; Kim YJ; Shin ES; Lee JW; Lee HJ; Ryu JS; Choi IK; Seo JH; Kim YH
    Lung Cancer; 2008 Nov; 62(2):152-61. PubMed ID: 18450319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
    Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
    Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.